ANDA 90787, held by Apotex Inc. Levofloxacin.
As of Nov 16, 2026, ANDA 90787 (Levofloxacin), held by Apotex Inc, was first approved by FDA on Sep 29, 2011, with 13 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 29, 2011 | Original application | Approved | None posted |
| Levofloxacin250MG · tablet;oral | Levofloxacin | Discontinued |
| Levofloxacin500MG · tablet;oral | Levofloxacin | Discontinued |
| Levofloxacin750MG · tablet;oral | Levofloxacin | Discontinued |
| Sep 20, 2024 | Supplement 14Labeling · Standard review | Approved | None posted |
| Feb 11, 2021 | Supplement 13Labeling · Standard review | Approved | None posted |
| Jun 2, 2020 | Supplement 12Labeling · Standard review | Approved | None posted |
| Jun 2, 2020 | Supplement 11Labeling · Standard review | Approved | None posted |
| May 6, 2019 | Supplement 10Labeling · Standard review | Approved | None posted |
| Apr 24, 2019 | Supplement 9Labeling · Standard review | Approved | None posted |
| Apr 24, 2019 | Supplement 8Labeling · Standard review | Approved | None posted |
| Apr 24, 2019 | Supplement 7Labeling · Standard review | Approved | None posted |
| Apr 24, 2019 | Supplement 6Labeling · Standard review | Approved | None posted |
| Sep 24, 2014 | Supplement 4Labeling · Standard review | Approved | None posted |
| Sep 24, 2014 | Supplement 3Labeling · Standard review | Approved | None posted |
| Jul 31, 2013 | Supplement 2Labeling · Standard review | Approved | None posted |
| Jul 22, 2013 | Supplement 1Labeling · Standard review | Approved | None posted |
| Sep 29, 2011 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters